140 related articles for article (PubMed ID: 26340519)
1. A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography.
Slotnick S; Ding Y; Glazman S; Durbin M; Miri S; Selesnick I; Sherman J; Bodis-Wollner I
Mov Disord; 2015 Oct; 30(12):1692-5. PubMed ID: 26340519
[TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease.
Mailankody P; Battu R; Khanna A; Lenka A; Yadav R; Pal PK
Parkinsonism Relat Disord; 2015 Oct; 21(10):1164-9. PubMed ID: 26297381
[TBL] [Abstract][Full Text] [Related]
3. A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease.
Miri S; Glazman S; Mylin L; Bodis-Wollner I
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S134-7. PubMed ID: 26414119
[TBL] [Abstract][Full Text] [Related]
4. Foveal vision is impaired in Parkinson's disease.
Bodis-Wollner I
Parkinsonism Relat Disord; 2013 Jan; 19(1):1-14. PubMed ID: 22998939
[TBL] [Abstract][Full Text] [Related]
5. Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases.
Murueta-Goyena A; Del Pino R; Reyero P; Galdós M; Arana B; Lucas-Jiménez O; Acera M; Tijero B; Ibarretxe-Bilbao N; Ojeda N; Peña J; Cortés J; Gómez-Esteban JC; Gabilondo I
Mov Disord; 2019 Sep; 34(9):1315-1324. PubMed ID: 31136022
[TBL] [Abstract][Full Text] [Related]
6. The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson's disease.
Bayhan HA; Aslan Bayhan S; Tanık N; Gürdal C
Curr Eye Res; 2014 Nov; 39(11):1117-22. PubMed ID: 24655112
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography in Parkinson's disease: is the retina a biomarker?
Lee JY; Ahn J; Kim TW; Jeon BS
J Parkinsons Dis; 2014; 4(2):197-204. PubMed ID: 24518436
[TBL] [Abstract][Full Text] [Related]
8. Photoreceptor layer thinning in idiopathic Parkinson's disease.
Roth NM; Saidha S; Zimmermann H; Brandt AU; Isensee J; Benkhellouf-Rutkowska A; Dornauer M; Kühn AA; Müller T; Calabresi PA; Paul F
Mov Disord; 2014 Aug; 29(9):1163-70. PubMed ID: 24789530
[TBL] [Abstract][Full Text] [Related]
9. Development of a prediction formula of Parkinson disease severity by optical coherence tomography.
Jiménez B; Ascaso FJ; Cristóbal JA; López del Val J
Mov Disord; 2014 Jan; 29(1):68-74. PubMed ID: 24458320
[TBL] [Abstract][Full Text] [Related]
10. Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease.
Adam CR; Shrier E; Ding Y; Glazman S; Bodis-Wollner I
J Neuroophthalmol; 2013 Jun; 33(2):137-42. PubMed ID: 23612240
[TBL] [Abstract][Full Text] [Related]
11. Application of an OCT data-based mathematical model of the foveal pit in Parkinson disease.
Ding Y; Spund B; Glazman S; Shrier EM; Miri S; Selesnick I; Bodis-Wollner I
J Neural Transm (Vienna); 2014 Nov; 121(11):1367-76. PubMed ID: 24748549
[TBL] [Abstract][Full Text] [Related]
12. Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomography.
Bittersohl D; Stemplewitz B; Keserü M; Buhmann C; Richard G; Hassenstein A
Acta Ophthalmol; 2015 Nov; 93(7):e578-84. PubMed ID: 26267660
[TBL] [Abstract][Full Text] [Related]
13. Remodeling of the fovea in Parkinson disease.
Spund B; Ding Y; Liu T; Selesnick I; Glazman S; Shrier EM; Bodis-Wollner I
J Neural Transm (Vienna); 2013 May; 120(5):745-53. PubMed ID: 23263598
[TBL] [Abstract][Full Text] [Related]
14. The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson's disease.
Pinkhardt EH; Ding Y; Slotnick S; Kassubek J; Ludolph AC; Glazman S; Selesnick I; Bodis-Wollner I
J Neural Transm (Vienna); 2020 Sep; 127(9):1275-1283. PubMed ID: 32676747
[TBL] [Abstract][Full Text] [Related]
15. Analysis of foveal characteristics and their asymmetries in the normal population.
Scheibe P; Zocher MT; Francke M; Rauscher FG
Exp Eye Res; 2016 Jul; 148():1-11. PubMed ID: 27191610
[TBL] [Abstract][Full Text] [Related]
16. Characterization of retinal architecture in Parkinson's disease.
Chorostecki J; Seraji-Bozorgzad N; Shah A; Bao F; Bao G; George E; Gorden V; Caon C; Frohman E; Bhatti MT; Khan O
J Neurol Sci; 2015 Aug; 355(1-2):44-8. PubMed ID: 26071887
[TBL] [Abstract][Full Text] [Related]
17. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease.
Garcia-Martin E; Satue M; Fuertes I; Otin S; Alarcia R; Herrero R; Bambo MP; Fernandez J; Pablo LE
Ophthalmology; 2012 Oct; 119(10):2161-7. PubMed ID: 22749083
[TBL] [Abstract][Full Text] [Related]
18. Reconstructing foveal pit morphology from optical coherence tomography imaging.
Dubis AM; McAllister JT; Carroll J
Br J Ophthalmol; 2009 Sep; 93(9):1223-7. PubMed ID: 19474001
[TBL] [Abstract][Full Text] [Related]
19. Retinal pathology detected by optical coherence tomography in an animal model of Parkinson's disease.
Schneider JS; Ault ME; Anderson DW
Mov Disord; 2014 Oct; 29(12):1547-51. PubMed ID: 25070726
[TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomography retinal thickness and volume measurements in X-linked retinoschisis.
Andreoli MT; Lim JI
Am J Ophthalmol; 2014 Sep; 158(3):567-73.e2. PubMed ID: 24879947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
